SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bajaj Healthcare - Quaterly Results

28 Jul 2025 Evaluate
A fair growth of 12.54% in the revenue at Rs. 1488.36 millions was reported in the June 2025 quarter as compared to Rs. 1322.47 millions during year-ago period.Profit after tax for the quarter ended June 2025 reported a huge growth of 51.69% to Rs. 121.75  millions from Rs. 80.26 millions.Operating profit surged to 253.88 millions from the corresponding previous quarter of 253.58 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1488.36 1322.47 12.54 1488.36 1322.47 12.54 5426.02 4734.18 14.61
Other Income 8.78 8.54 2.81 8.78 8.54 2.81 194.04 86.86 123.39
PBIDT 253.88 253.58 0.12 253.88 253.58 0.12 1018.31 849.51 19.87
Interest 52.26 84.44 -38.11 52.26 84.44 -38.11 279.04 296.80 -5.98
PBDT 201.62 169.14 19.20 201.62 169.14 19.20 739.27 109.43 575.56
Depreciation 56.36 67.30 -16.26 56.36 67.30 -16.26 279.18 276.20 1.08
PBT 145.26 101.84 42.64 145.26 101.84 42.64 460.09 -166.77 -375.88
TAX 23.51 21.58 8.94 23.51 21.58 8.94 30.79 -23.49 -231.08
Deferred Tax 23.51 21.58 8.94 23.51 21.58 8.94 30.79 -37.05 -183.10
PAT 121.75 80.26 51.69 121.75 80.26 51.69 429.30 -143.28 -399.62
Equity 157.92 137.99 14.44 157.92 137.99 14.44 157.92 137.99 14.44
PBIDTM(%) 17.06 19.17 -11.04 17.06 19.17 -11.04 18.77 17.94 4.59

Bajaj Healthcare Share Price

348.95 -1.50 (-0.43%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×